RECRUITING

A Supervised Prehabilitation Program for Patients with Pancreatic Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to assess the use of an exercise program in people with pancreatic cancer.

Official Title

A Supervised Prehabilitation Program for Patients with Pancreatic Cancer

Quick Facts

Study Start:2023-04-04
Study Completion:2026-04-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05692323

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Pancreatic cancer diagnosis (any stage)
  2. * Age ≥ 18 years
  3. * Independent ambulation and activities of daily living (Discretion of referring/ treating oncologist)
  4. * Godin-Shephard Leisure-Time Physical Activity Questionnaire score of ≤ 23
  5. * Physically able to complete functional assessments including 6-minute walk test, hand grip strength, short performance physical battery and performance metrics
  6. * Answers no to all questions on PAR-Q OR is cleared to participate by their treating oncologist
  7. * Ability to read, write and understand English
  8. * Written informed consent obtained from subject and ability for subjects to comply with the requirements of the study
  9. * Access to a smart device capable of Fitbit syncing and accessing the online Pain portal (www.painguide.com)
  1. * Has undergone or plans to undergo resection surgery prior to projected completion of PREHAB exercise intervention
  2. * Current pregnancy
  3. * Using a pacemaker, implantable cardiac defibrillator, neurostimulator, cochlear implants (removable hearing aids permitted), or other electronic medical equipment, unless the PI deems study participation safe.

Contacts and Locations

Study Contact

Philip Chang, DO
CONTACT
310 467 4498
philip.chang@cshs.org

Principal Investigator

Philip Chang, DO
PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center

Study Locations (Sites)

Cedars-Sinai Medical Center
Los Angeles, California, 90048
United States

Collaborators and Investigators

Sponsor: Cedars-Sinai Medical Center

  • Philip Chang, DO, PRINCIPAL_INVESTIGATOR, Cedars-Sinai Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-04
Study Completion Date2026-04-01

Study Record Updates

Study Start Date2023-04-04
Study Completion Date2026-04-01

Terms related to this study

Keywords Provided by Researchers

  • Exercise
  • Prehabilitation

Additional Relevant MeSH Terms

  • Pancreas Cancer